Stocks of Elanco Animal Health Inc (NYSE:ELAN) traded higher last session on Wall Street, down -1.06% to $13.08.
ELAN stock price is now 26.94% away from the 50-day moving average and 6.41% away from the 200-day moving average. The market capitalization of the company currently stands at $6.50B.
With the price target of $18, UBS recently initiated with Buy rating for Elanco Animal Health Inc (NYSE: ELAN). On December 02, 2024, Leerink Partners recently initiated its ‘Market Perform’ rating on the stock quoting a target price of $14, while ‘Morgan Stanley’ rates the stock as ‘Equal-Weight’
In other news, Kurzius Lawrence Erik, Director bought 10,000 shares of the company’s stock on Mar 07 ’25. The stock was bought for $109,000 at an average price of $10.90. Upon completion of the transaction, the Director now directly owns 101,459 shares in the company, valued at $1.33 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 11 ’25, Director Kurzius Lawrence Erik bought 10,000 shares of the business’s stock. A total of $102,000 was incurred on buying the stock at an average price of $10.20. This leaves the insider owning 111,459 shares of the company worth $1.46 million. A total of 0.95% of the company’s stock is owned by insiders.
During the past 12 months, Elanco Animal Health Inc has had a low of $8.02 and a high of $18.80. As of last week, the company has a debt-to-equity ratio of 0.69, a current ratio of 2.71, and a quick ratio of 1.46.
The net profit margin was 8.43% and return on equity was 6.01% for ELAN.
